Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)

Joshua F Zeidner, MD, Tara L Lin, MD, Carlos E Vigil, MD, Andrew Dalovisio, MD, Eunice S. Wang, MD, Moshe Yair Levy, MD, Mark G. Frattini, MD PhD, Daniel J. Lee, MD, Pau Montesinos, MD PhD, Juan Miguel Miguel Bergua Burgues, Jeffrey R. Schriber, MD, Stephen Anthony, DO, David J. Bearss, PhD, B. Douglas Smith, MD

Blood (2018) 132 (Supplement 1): 30.

https://doi.org/10.1182/blood-2018-99-115018

Published: 2018

Journal Articles

Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

Jeffrey R. Schriber, MD, Parmeswaran Hari, MD MRCP, MS, Kwang Woo Ahn, PhD, Mingwei Fei, MS, Amrita Krishnan, MD, Anita D'Souza, MBBS, MD

Blood (2016) 128 (22): 1190.

https://doi.org/10.1182/blood.V128.22.1190.1190

Published: 2016

Journal Articles

Autologous Stem Cell Transplantation For Multiple Myeloma In Patients Over Age 70: Decision Making, Eligibility, and Preliminary Outcomes

Jeffrey R. Schriber, MD, Aleksandra E Schriber, Gail Sulski, FNP, Nicole Thurman, FNP, Rochelle Chiffelle, DNP, Anthony Szetela, PharmD, Denise Gibson, MSN, AOCNS, Abbas Jonathan, MD, Selma Kendrick, RN, MS, Adrienne D. Briggs, MD

Blood (2013) 122 (21): 3395.

https://doi.org/10.1182/blood.V122.21.3395.3395

Published: 2013

Journal Articles

Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Adult Patients with Non-Hematologic Malignancies

Mitchell E. Horwitz, MD, Edward Gorak, Peter Holman, MD, Edward Libby, MD, Dirk Huebner, MD, Purvi D Mody, PhD, Jeffrey R. Schriber, MD

Blood (2010) 116 (21): 2249.

https://doi.org/10.1182/blood.V116.21.2249.2249

Published: 2010

Journal Articles

Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR

Jeffrey R. Schriber, MD, Manza- A Agovi, MPH, Karen K Ballen, MD, Andrea Bacigalupo, MD, Gregory A. Hale, MD, Vikas Gupta, MD, MRCP, MRCPath, Hillard M. Lazarus, MD, Mark R. Litzow, MD, David I. Marks, MD, Roger H. Giller, MD, Richard T. Maziarz, MD, Martin Bornhauser, MD, Luis M. Isola, MD, Christopher Bredeson, MD, J. Douglas Rizzo, MD, MS

Blood (2008) 112 (11): 794.

https://doi.org/10.1182/blood.V112.11.794.794

Published: 2008

NARROW

Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)

Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

Autologous Stem Cell Transplantation For Multiple Myeloma In Patients Over Age 70: Decision Making, Eligibility, and Preliminary Outcomes

Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Adult Patients with Non-Hematologic Malignancies

Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR

Email alerts

ASH Publications

American Society of Hematology

Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)

Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

Autologous Stem Cell Transplantation For Multiple Myeloma In Patients Over Age 70: Decision Making, Eligibility, and Preliminary Outcomes

Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Adult Patients with Non-Hematologic Malignancies

Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only